New
FOR ADULT ACNE-PRONE SKIN
Persistent imperfections and marks. Visible pores.

Specifically adapted and well-tolerated for acne-prone skin.
Non-comedogenic.

Tested on acne-prone skin. Avoid eye area. In contact with eyes, rinse thoroughly. Use in association with a daily photo-protection product (SPF > 15). Do not apply on open scars.

Validity after opening:
12 Months
  • Bottle
  • Adults
  • Reduces imperfections. 
    Reduces marks. 
    Reduces visible pores. 
    Mattifying & Soothing. 
  • Face
Volume
3337875722827

30 ml

bag

IT'S PROVEN
IMMEDIATE AND DURABLE EFFICACY

PictoChrono

HIGH CLINICAL EFFICACY 
-45%
pimples*
-50% blackheads**
-49% marks*

Clinical test, 51 women, once daily application for 4 weeks. * After 28 days ** After 44 days  

Bar

VISIBLE EFFICACY FROM THE FIRST MORNING
83%
Skin looks smoother and texture appears refined

EFFICACY IN 14 DAYS 
90% Fine lines are reduced 
100% The skin is comfortable 
92% Pores are less visible *

*Self assessment, first morning and 14 days. 

EXPERT
QUOTE

Avoid friction and scratching when cleansing or applying your skincare. Avoid touching skin as much as possible, keep nails short and avoid sun exposure, as it might worsen blemishes.

THE PERFECT MATCH
FOR YOUR SKIN

THE EFFACLAR WINNING TRIO

To help you sooth and reduce your imperfections and marks, we recommend this 3 step routine for adult acne-prone skin.
ADULT ACNE PRONE SKIN 

SPOTSCAN+
FOR ACNE-PRONE SKIN
INSTANT SKIN ANALYSIS
POWERED BY AI
DEVELOPED 
WITH DERMATOLOGISTS

Our skin analysis tool combines La Roche Posay’s dermatological expertise with A.I. to find the best routine for your acne-prone skin.

DISCOVER THE OTHER
PRODUCTS OF THE RANGE

EFFACLAR is a complete range of anti-imperfection solutions that targets all the stages of the imperfection life cycle with a high efficacy, while ensuring a perfect tolerance.

Did you
know?

DidYouKnow_Desktop_1

The 3-step EFFACLAR routine
– cleanse, correct, protect – shows proven effectiveness
on patients with acne-prone skin living in polluted environments.*

*Quantitative study, Beijing/Shanghai, 2014, Total sample: n=600 ²DIM Sell-in YTD Sept 2015 ³INS/Kantar Health La Roche-Posay Barometers 2013